WALTHAM, Mass., Aug. 20 /PRNewswire-FirstCall/ -- Thermo Fisher
Scientific Inc. (NYSE: TMO) announced today that certain executive
officers, including Marijn E. Dekkers, president and chief executive
officer, are adopting stock- trading programs under Securities and Exchange
Commission (SEC) Rule 10b5-1 covering the future sale of company stock. Mr.
Dekkers, who exercised options for and sold 300,000 shares over August
15-17, 2007, has adopted a plan for the future sale of up to an additional
780,000 shares, which he would acquire upon the exercise of stock options
granted in 2002. Mr. Dekkers entered into this program in order to
diversify his financial holdings, although he will continue to have a
significant ownership interest in the company. After selling these shares,
Mr. Dekkers would own shares, or share equivalents, and hold options
totaling 1,860,378 shares.
These trading programs are based on SEC Rule 10b5-1, which protects
company executives from possible claims of insider trading by permitting
them to buy or sell a predetermined amount of their company's shares, as
set forth in a planned acquisition or divestiture program that was adopted
when the insider did not possess any material non-public information.
About Thermo Fisher Scientific
Thermo Fisher Scientific (NYSE: TMO) is the world leader in serving
science, enabling our customers to make the world healthier, cleaner and
safer. With an annual revenue rate of more than $9 billion, we employ
30,000 people and serve over 350,000 customers within pharmaceutical and
biotech companies, hospitals and clinical diagnostic labs, universities,
research institutions and government agencies, as well as environmental and
industrial process control settings. Serving customers through two premier
brands, Thermo Scientific and Fisher Scientific, we help solve analytical
challenges from routine testing to complex research and discovery. Thermo
Scientific offers customers a complete range of high-end analytical
instruments as well as laboratory equipment, software, services,
consumables and reagents to enable integrated laboratory workflow
solutions. Fisher Scientific provides a complete portfolio of laboratory
equipment, chemicals, supplies and services used in healthcare, scientific
research, safety and education. Together, we offer the most convenient
purchasing options to customers and continuously advance our technologies
to accelerate the pace of scientific discovery, enhance value for customers
and fuel growth for shareholders and employees alike. Visit
http://www.thermofisher.com .
Media Contact Information: Investor Contact Information:
Lori Gorski Ken Apicerno
Phone: 781-622-1242 Phone: 781-622-1111
E-mail: lori.gorski@thermofisher.com E-mail: ken.apicerno@thermofisher.com
Website: http://www.thermofisher.com
SOURCE Thermo Fisher Scientific Inc.
 back to top
Related links:
http://www.thermofisher.com
http://www.prnewswire.com/comp/877850.html /
CONTACT:
Media: Lori Gorski, +1-781-622-1242,
lori.gorski@thermofisher.com, or Investors: Ken Apicerno,
+1-781-622-1111, ken.apicerno@thermofisher.com, both of Thermo
Fisher Scientific Inc.
|
